Effects of a respiratory and neurological rehabilitation treatment plan in post Covid-19 affected university students. Randomized clinical study.
Zacarías Sánchez MiláDavid Rodríguez SanzAna Martín NietoAna Jiménez LoboManuel Ramos HernándezAngélica Campón ChekrounRaúl Frutos LlanesJosé Manuel Barragán CasasJorge Velázquez SaornilPublished in: Chronic respiratory disease (2024)
The implementation of a respiratory rehabilitation treatment plan with the Powerbreathe Plus® device, aerobic exercise and neurorehabilitation with olfactory and gustatory training, is a therapeutic option against respiratory and neurological sequelae in patients who have suffered such sequelae due to the SARS-CoV-2 virus. Clinicaltrials.gov: NCT05195099. First posted 18/01/2022; Last Update Posted 29/06/2022.
Keyphrases
- sars cov
- end stage renal disease
- coronavirus disease
- chronic kidney disease
- ejection fraction
- healthcare
- primary care
- newly diagnosed
- randomized controlled trial
- clinical trial
- peritoneal dialysis
- open label
- respiratory syndrome coronavirus
- prognostic factors
- combination therapy
- patient reported outcomes
- patient reported